OIA
RGNX icon

Optimum Investment Advisors’s Regenxbio RGNX Stock Holding History

Optimum Investment Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20
Closed -$1K – 914
2020
Q1 		$1K Hold
20
– – ﹤0.01% 850
2019
Q4 		$1K Hold
20
– – ﹤0.01% 926
2019
Q3 		$1K Buy
+20
New +$810 ﹤0.01% 972

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optimum Investment Advisors's RGNX Position: Q2 2020 in Review

Optimum Investment Advisors sold out of Regenxbio (RGNX) in Q2 2020, closing a stake of 20 shares — an estimated $1K sold.

Optimum Investment Advisors first reported a position in RGNX in Q3 2019 and held it in 3 quarters. The position peaked at $1K in Q1 2020. 179 funds tracked by Wall St. Rank hold RGNX as of Q2 2020.

  • Optimum Investment Advisors reported no remaining Regenxbio position as of Q2 2020 after selling out during the quarter.
  • Optimum Investment Advisors sold 20 Regenxbio shares in Q2 2020, an estimated $1K.
  • Optimum Investment Advisors first reported a position in Regenxbio in Q3 2019 and held it in 3 quarters.
  • Optimum Investment Advisors's Regenxbio position peaked at $1K in Q1 2020.
  • 179 funds tracked by Wall St. Rank held Regenxbio as of Q2 2020.

Based on Optimum Investment Advisors's 13F filing for Q2 2020, filed 16 Jul 2020.